S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast
about
Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesisS100A7 and the progression of breast cancerHighly homologous hS100A15 and hS100A7 proteins are distinctly expressed in normal breast tissue and breast cancerStructural and functional characterization of a triple mutant form of S100A7 defective for Jab1 bindingNovel S100A7 (psoriasin)/S100A15 (koebnerisin) subfamily: highly homologous but distinct in regulation and functionComprehensive serial analysis of gene expression of the cervical transcriptome.Regulation of Cop9 signalosome activity by the EF-hand Ca2+-binding protein tescalcinMolecular and cellular impact of Psoriasin (S100A7) on the healing of human wounds.Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodelingThe emerging role of the COP9 signalosome in cancer.Differential occurrence of S100A7 in breast cancer tissues: a proteomic-based investigation.Distinct innate immune gene expression profiles in non-melanoma skin cancer of immunocompetent and immunosuppressed patientsThe expression of Psoriasin (S100A7) and CD24 is linked and related to the differentiation of mammary epithelial cells.S100 proteins in cancer.Tumor-suppressive effects of psoriasin (S100A7) are mediated through the β-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells.The Characteristics and Function of S100A7 Induction in Squamous Cell Carcinoma: Heterogeneity, Promotion of Cell Proliferation and Suppression of DifferentiationProgression of Ductal Carcinoma in Situ from the Pathological Perspective.Distinct prognostic values of S100 mRNA expression in breast cancer.Psoriasin (S100A7) associates with integrin β6 subunit and is required for αvβ6-dependent carcinoma cell invasion.S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer.Jab1 is a target of EGFR signaling in ERalpha-negative breast cancer.Psoriasin promotes invasion, aggregation and survival of pancreatic cancer cells; association with disease progression.Apocrine cysts of the breast: biomarkers, origin, enlargement, and relation with cancer phenotype.Psoriasin (S100A7): a novel mediator of angiogenesis.
P2860
Q21261220-8C09FEA1-F9CC-4785-B257-C2BF17A01939Q22000741-7CA8BEAC-6DDE-4BB9-979F-4C8D518485FAQ24646504-B386EB4C-673A-4197-A33B-660F7387C4DFQ27657867-18855080-1D8B-41E6-994A-5B0015004F97Q28286769-D0C0C15C-C4BC-4869-B0CF-7A99F934575AQ33286443-ED89C324-58F3-4901-B2F5-C2DA3FF20454Q33687600-01186732-2F5A-46EC-9B3A-F8A36A7C8FC8Q33724031-E9DA31C6-D743-4605-B266-569D36811176Q33804642-C821E32B-B63A-4BE5-B728-B55E1815849FQ34147948-0FAAE4FE-3113-4824-A779-37911D53823DQ34284848-BFECED34-F73E-4348-88CC-DC3DDC187137Q34342371-92F98C3F-6DEC-4358-AD6E-C38B6D46E2A7Q34541694-0E8F708C-0F19-46A5-977C-8DC731F3451FQ35206368-94D033D8-499D-4A71-8979-EEC7CED3281AQ35639956-CD4EA131-0746-4C18-8BB1-C7A53AA82615Q35656741-00CC5F7A-6749-4CFB-AEA7-0A64FC477FC0Q35940085-3837DDA5-6044-4B1D-80CD-2E9B3EF1DA98Q37554595-49865077-503B-4F06-9520-F93A6AC741FEQ39623720-D3AD0A00-B43D-49A5-8C43-B19411F43037Q39747948-0092081C-BC85-47FB-A7E9-766C6BFC9802Q39974866-6172A470-963D-4F57-86B0-4A2F7DFD4310Q41811874-9A089B3C-495A-4274-BEBF-946323E90F88Q46827099-B377D469-B117-4123-8946-53CA1707D9EBQ51248692-E8491F0A-A471-4AE3-BB84-7B26795AC225
P2860
S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast
description
2004 nî lūn-bûn
@nan
2004 թուականին հրատարակուած գիտական յօդուած
@hyw
2004 թվականին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
S100A7 (psoriasin) expression ...... arcinoma in situ of the breast
@ast
S100A7 (psoriasin) expression ...... arcinoma in situ of the breast
@en
S100A7 (psoriasin) expression ...... arcinoma in situ of the breast
@nl
type
label
S100A7 (psoriasin) expression ...... arcinoma in situ of the breast
@ast
S100A7 (psoriasin) expression ...... arcinoma in situ of the breast
@en
S100A7 (psoriasin) expression ...... arcinoma in situ of the breast
@nl
prefLabel
S100A7 (psoriasin) expression ...... arcinoma in situ of the breast
@ast
S100A7 (psoriasin) expression ...... arcinoma in situ of the breast
@en
S100A7 (psoriasin) expression ...... arcinoma in situ of the breast
@nl
P2093
P2860
P356
P1476
S100A7 (psoriasin) expression ...... arcinoma in situ of the breast
@en
P2093
Ethan D Emberley
Leigh C Murphy
Linda Snell
Peter H Watson
Salem Alowami
P2860
P2888
P304
P356
10.1186/BCR791
P407
P577
2004-01-01T00:00:00Z
P5875
P6179
1047461373